JP2023540485A5 - - Google Patents
Info
- Publication number
- JP2023540485A5 JP2023540485A5 JP2023513628A JP2023513628A JP2023540485A5 JP 2023540485 A5 JP2023540485 A5 JP 2023540485A5 JP 2023513628 A JP2023513628 A JP 2023513628A JP 2023513628 A JP2023513628 A JP 2023513628A JP 2023540485 A5 JP2023540485 A5 JP 2023540485A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- patient
- agent according
- beta
- blocker therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063072094P | 2020-08-28 | 2020-08-28 | |
| US63/072,094 | 2020-08-28 | ||
| PCT/US2021/047711 WO2022047004A1 (en) | 2020-08-28 | 2021-08-26 | Methods of treatment with myosin modulator |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540485A JP2023540485A (ja) | 2023-09-25 |
| JP2023540485A5 true JP2023540485A5 (enExample) | 2024-09-09 |
Family
ID=80355673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513628A Pending JP2023540485A (ja) | 2020-08-28 | 2021-08-26 | ミオシンモジュレーターによる治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12616697B2 (enExample) |
| EP (1) | EP4203927A4 (enExample) |
| JP (1) | JP2023540485A (enExample) |
| KR (1) | KR20230079053A (enExample) |
| CN (1) | CN116490185A (enExample) |
| AU (1) | AU2021334316A1 (enExample) |
| CA (1) | CA3190060A1 (enExample) |
| IL (1) | IL300775A (enExample) |
| MX (1) | MX2023002024A (enExample) |
| WO (1) | WO2022047004A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202006296YA (en) | 2018-01-19 | 2020-08-28 | Cytokinetics Inc | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors |
| JP7438148B2 (ja) | 2018-06-26 | 2024-02-26 | サイトキネティックス， インコーポレイテッド | 心臓サルコメア阻害剤 |
| EP3814343B1 (en) | 2018-06-26 | 2023-01-11 | Cytokinetics, Inc. | Cardiac sarcomere inhibitors |
| MA53491A (fr) | 2018-08-31 | 2021-09-15 | Cytokinetics Inc | Inhibiteurs de sarcomes cardiaques |
| US11488702B2 (en) | 2019-07-18 | 2022-11-01 | Physiq, Inc. | System and method for improving cardiovascular health of humans |
| KR20240015622A (ko) | 2021-03-04 | 2024-02-05 | 싸이토키네틱스, 인코포레이티드 | 심장 근절 억제제 |
| EP4370116B1 (en) | 2021-07-16 | 2025-01-15 | Cytokinetics, Inc. | Aficamten dosage regimens for treating obstructive hypertrophic cardiomyopathy |
| WO2023133163A1 (en) | 2022-01-05 | 2023-07-13 | Prolaio, Inc. | System and method for monitoring an efficacy of a treatment for a cardiac condition |
| CN119789856A (zh) * | 2022-04-26 | 2025-04-08 | 迈奥卡迪亚公司 | 施用肌球蛋白抑制剂的方法 |
| EP4604841A1 (en) * | 2022-10-21 | 2025-08-27 | Prolaio, Inc. | System and method of treatment of hypertrophic cardiomyopathy |
| WO2024182469A1 (en) * | 2023-02-28 | 2024-09-06 | MyoKardia, Inc. | Myosin inhibitors for use in the treatment of hypertrophic cardiomyopathy |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9199945B2 (en) | 2013-06-21 | 2015-12-01 | MyoKardia, Inc. | Cycloalkyl-substituted pyrimidinedione compounds |
| SMT202000071T1 (it) * | 2013-06-21 | 2020-03-13 | Myokardia Inc | Composti di pirimidinadione contro le condizioni cardiache |
| US9663516B2 (en) | 2014-12-18 | 2017-05-30 | MyoKardia, Inc. | Bicyclic-pyrimidinedione compounds |
| IL322175A (en) * | 2017-08-04 | 2025-09-01 | Myokardia Inc | Treatment of hypertrophic cardiomyopathy (HCM) with pyrimidinedione compounds |
| SG11202006296YA (en) | 2018-01-19 | 2020-08-28 | Cytokinetics Inc | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors |
| JP7438148B2 (ja) | 2018-06-26 | 2024-02-26 | サイトキネティックス， インコーポレイテッド | 心臓サルコメア阻害剤 |
| EP3814343B1 (en) | 2018-06-26 | 2023-01-11 | Cytokinetics, Inc. | Cardiac sarcomere inhibitors |
| MA53491A (fr) | 2018-08-31 | 2021-09-15 | Cytokinetics Inc | Inhibiteurs de sarcomes cardiaques |
| IL325304A (en) * | 2018-10-29 | 2026-02-01 | Myokardia Inc | 4-Tetrahydropyran-4-yl-6-fluoro-7-phenyl-8,7,6,5-tetrahydro-h1-pyrido[3,2-d]pyrimidine-2,4-dione |
| WO2020151605A1 (zh) | 2019-01-25 | 2020-07-30 | 青岛吉澳医药科技有限公司 | 氘代苯甲氨嘧啶二酮衍生物及其用途 |
| WO2020165247A1 (de) | 2019-02-12 | 2020-08-20 | Basf Polyurethanes Gmbh | Stossdämpferanordnung für eine fahrzeugfederung, und verwendung eines gleitmittels für selbige |
| WO2020257609A1 (en) | 2019-06-21 | 2020-12-24 | MyoKardia, Inc. | Diagnostics and treatments for cardiac disease |
| CN110698415B (zh) * | 2019-10-21 | 2023-05-09 | 上海先行医药开发有限公司 | 一种肌球蛋白抑制剂及其制备方法和用途 |
| CA3157629A1 (en) * | 2019-11-10 | 2021-05-14 | MyoKardia, Inc. | Methods of treatment with myosin modulator |
-
2021
- 2021-08-26 KR KR1020237009983A patent/KR20230079053A/ko active Pending
- 2021-08-26 IL IL300775A patent/IL300775A/en unknown
- 2021-08-26 US US18/042,632 patent/US12616697B2/en active Active
- 2021-08-26 MX MX2023002024A patent/MX2023002024A/es unknown
- 2021-08-26 JP JP2023513628A patent/JP2023540485A/ja active Pending
- 2021-08-26 CN CN202180070780.5A patent/CN116490185A/zh active Pending
- 2021-08-26 AU AU2021334316A patent/AU2021334316A1/en active Pending
- 2021-08-26 EP EP21862716.4A patent/EP4203927A4/en active Pending
- 2021-08-26 WO PCT/US2021/047711 patent/WO2022047004A1/en not_active Ceased
- 2021-08-26 CA CA3190060A patent/CA3190060A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102056603A (zh) | 决奈达隆用于预防持续性心房纤颤 | |
| JP2020529996A5 (enExample) | ||
| TW200948354A (en) | Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality | |
| Koike et al. | Atrial automatic tachycardia in children | |
| JP5643213B2 (ja) | 肥大性心筋症治療用のホスホジエステラーゼタイプＩＩＩ（ＰＤＥＩＩＩ）インヒビターまたはＣａ２＋感作剤 | |
| JP2025515491A5 (enExample) | ||
| CN102065857A (zh) | 决奈达隆或其可药用盐在制备用于调节血钾水平的药物中的用途 | |
| Gursoy et al. | New-onset acute heart failure after intravenous glucocorticoid pulse therapy in a patient with Graves' ophthalmopathy | |
| TW589184B (en) | Pharmaceutical composition for preventing or reversing diabetic cardiomyopathy | |
| TW201002314A (en) | Use of dronedarone for the preparation of a medicament for use in the prevention of cardioversion | |
| TW200951117A (en) | Combination of dronedarone with at least one diuretic, therapeutic application thereof | |
| CN108815171B (zh) | 25-羟基胆固醇在制备治疗或预防心肌梗死的药物中的应用 | |
| US4565830A (en) | Method of ameliorating the subjective symptoms and objective signs in congestive heart failure | |
| EP1196152A1 (en) | Use of cortisol antagonists in the treatment for heart failure | |
| Antani | Prazosin in hypertension with heart failure | |
| JP2022116278A5 (enExample) | ||
| CN116940356A (zh) | 用于治疗致心律失常性心肌病的组合物和方法 | |
| Conti | Re‐thinking angina | |
| JP2010248263A (ja) | 塩酸ランジオロールを含有する頻脈性不整脈の治療剤 | |
| Mori et al. | Right Ventricular Pacing as Rescue Therapy for Cardiogenic Shock in Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction | |
| JP4784037B2 (ja) | 塩酸ランジオロールを含有する頻脈性不整脈の治療剤 | |
| RU2320328C2 (ru) | Способ лечения персистирующей формы фибрилляции предсердий | |
| JP2025504706A5 (enExample) | ||
| Colson et al. | Life-threatening pheochromocytoma crisis operated on emergency under extracorporeal life support: about 4 case reports | |
| WO2026098240A1 (zh) | 萜品烯醇类化合物在制备治疗心脏疾病的药物中的应用 |